Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy
2008
154 citations
Journal Article
green Open Access
Field-Weighted Citation Impact:
3.04
The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy | Researchclopedia
Technical University of Munich
Paul N. Span
·
Radboud University Medical Center
David G. Hicks
·
University of Rochester Medical Center
Joseph P. Crowe
·
Cleveland Clinic
Raymond R. Tubbs
·
Cleveland Clinic
G. Thomas Budd
·
Cleveland Clinic
Joanne Lyons
·
Cleveland Clinic
Fred C.G.J. Sweep
·
Radboud University Nijmegen
Manfred Schmitt
·
Technical University of Munich
Francesco Schittulli
·
Istituto Tumori Bari
Rastko Golouh
·
Institute of Oncology Ljubljana
Dmitri Talantov
·
Johnson & Johnson (Sweden)
Yixin Wang
·
Johnson & Johnson (United States)
John A. Foekens
·
Erasmus MC Cancer Institute